In one example, a cancer patient treated with anti-HER2/neu CAR T cells experienced symptoms of respiratory distress as early as 15 minutes after infusion, and quickly developed severe CRS that led to multi-organ failure and death 50. This evidence concerns the gene ERBB2 and congenital rubella syndrome.